Turmeric Supplements Tied to Rare Liver Injuries as New Case Reports Surface
Turmeric supplements have been tied to rare but rising liver injuries; researchers warn enhanced absorption, piperine additives, and genetic factors may raise risk.
New reports presented at the American College of Gastroenterology meeting and a clinical analysis from the U.S. Drug-Induced Liver Injury Network (DILIN) have drawn renewed attention to turmeric supplements and potential liver harm. The research links a small number of suspected drug-induced liver injury cases to turmeric formulations, and investigators say changes in how supplements are formulated may be increasing systemic exposure. Physicians and scientists urge awareness of warning signs and better case reporting as investigations continue.
ACG meeting presented 15 turmeric-related case studies
Researchers at the American College of Gastroenterology described 15 distinct case studies tying turmeric use to liver injury, drawing on clinical investigations across multiple centers. Presenters reported consistent clinical patterns among affected patients, prompting clinicians to consider turmeric in evaluations of unexplained hepatitis. The session renewed interest in earlier DILIN findings and stimulated calls for closer tracking of supplement-associated liver events.
DILIN data show small but notable fraction linked to turmeric
A 2022 DILIN analysis examined more than 2,000 suspected drug-induced liver injury reports and identified 345 cases attributed to herbal or dietary supplements. Of those, 10 cases were linked to turmeric products, all occurring after 2011 and most since 2017, with one fatality among the cohort. Investigators noted that while the absolute number remains low relative to the millions who take these supplements, the temporal clustering and clinical similarity of cases warranted further study.
Clinical pattern: middle-aged women and early symptom onset
The cases described in both the DILIN review and ACG presentations tended to involve middle-aged adults, often women, who were using turmeric for arthritis, pain, or general wellness. Symptoms typically emerged within about three months of starting the supplement, with fatigue, nausea and jaundice commonly reported. In several instances clinicians only linked the liver injury to turmeric after symptoms resolved when the supplement was stopped and recurred on re-exposure.
Formulation changes and piperine may increase bioavailability
Investigators highlighted that modern turmeric supplements are sometimes engineered for greater absorption, which can raise the amount of curcumin and related compounds reaching the bloodstream. Several products obtained from affected patients contained piperine (black pepper extract), an additive known to substantially increase curcumin’s systemic bioavailability. Experts caution that higher internal exposure could increase the liver’s contact with these compounds and, for a small subset of users, raise the risk of toxicity.
*Genetic marker HLA-B35:01 observed in many cases**
Genetic testing performed on affected individuals revealed that a majority of the small sample carried the HLA-B35:01 allele, a human leukocyte antigen previously linked to liver injury from other herbal products. Seven of ten patients in one dataset carried this allele, providing a possible clue to susceptibility but not proof of causation. Researchers stressed that the sample size is limited and that more genetic and epidemiologic work is needed to determine whether HLA-B35:01 confers meaningful risk for turmeric-associated liver injury.
Advice for clinicians and consumers on detection and reporting
Clinicians are being urged to ask patients specifically about supplement use when evaluating unexplained liver tests, since many patients assume over-the-counter products are irrelevant to clinicians. Common warning signs include abdominal pain, persistent nausea and yellowing of the skin or eyes; any of these should prompt medical evaluation and discontinuation of the supplement until the cause is clarified. Investigators also encouraged physicians and patients to report suspected cases to networks such as DILIN to help build a clearer picture of risk factors and outcomes.
Public health considerations and research priorities
Turmeric remains widely used and was among the top-selling herbal supplements in recent years, making surveillance of rare adverse events important despite their low absolute frequency. Experts emphasize that current evidence does not justify broad recalls or panic, but does support targeted research into formulation effects, interaction with additives like piperine, and host genetic susceptibility. Regulators, manufacturers and academic groups may need to collaborate on improved product labeling, post-market monitoring and mechanistic studies to refine safety guidance.
Most people who take turmeric supplements experience no serious problems, but clinicians say the new case reports underline the need for vigilance. Patients with existing liver disease or previous sensitivity to medications should be particularly cautious, and anyone who develops persistent digestive symptoms or jaundice after starting a supplement should seek prompt evaluation and inform their provider about all products they are taking.
